10 studies found for:    Open Studies | "Cardiac Output, Low"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Myocardial Protection With Perhexiline in Left Ventricular Hypertrophy
Conditions: Myocardial Reperfusion Injury;   Cardiac Output, Low;   Hypertrophy, Left Ventricular
Interventions: Drug: Perhexiline;   Drug: Placebo marked PEXSIG
2 Recruiting Changes in Cardiac Output During Delayed Umbilical Cord Clamping
Condition: Cardiac Output, Low
Intervention:
3 Recruiting Effects of Inspiratory Flow Waveforms on Preload
Condition: Cardiac Output, Low
Intervention: Device: varying inspiratory flow waveforms
4 Unknown  Prophylactic Use of Levosimendan Versus Milrinone in Open Heart Surgery in Infants
Condition: Low Cardiac Output Syndrome
Interventions: Drug: Levosimendan;   Drug: Milrinone
5 Unknown  Hemodynamic Evaluation of Preload Responsiveness in Children by Using PiCCO
Conditions: Shock;   Sepsis;   Systemic Inflammatory Response Syndrome;   Low Cardiac Output;   Dilated Cardiomyopathy
Intervention:
6 Not yet recruiting Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass
Conditions: Coronary Artery Bypass Grafting;   Mitral Valve Surgery;   Low Cardiac Output Syndrome
Interventions: Drug: Levosimendan;   Drug: Placebo
7 Recruiting Remote Ischemic Preconditioning in High Risk Cardiovascular Surgery Patients
Conditions: Death;   Stroke;   Low Cardiac Output Syndrome;   Myocardial Infarction;   Renal Failure;   Pulmonary Failure
Interventions: Other: Remote ischemic preconditioning stimulus;   Other: control
8 Recruiting Levosimendan in High Risk Patients Undergoing Cardiac Surgery
Condition: Low Cardiac Output Syndrome
Interventions: Drug: Levosimendan;   Drug: placebo
9 Recruiting NIRS Predict Low Cardiac Output State in Neonates and Infants in Cardiac Surgery
Condition: Congenital Heart Disease
Intervention: Device: EQUANOX Advance 8004CB sensor
10 Recruiting Preoperative Levosimendan in CABG Patients With Poor LV Function
Conditions: Coronary Artery Bypass Grafting;   Left Ventricular Dysfonction
Interventions: Drug: levosimendan;   Drug: Placebo

Indicates status has not been verified in more than two years